VEGF-C contributes to head and neck squamous cell carcinoma growth and motility

Oral Oncology

Volumn 46, Issue 4, 2010, Pages

  Benke, Emily M ^a   Ji, Youngmi ^c   Patel, Vyomesh ^d   Wang, Huixin ^a   Miyazaki, Hiroshi ^a   Yeudall, W Andrew ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Motility; Oral cancer; Proliferation; Squamous cell carcinoma; Vascular endothelial cell growth factor

Indexed keywords

COMPLEMENTARY DNA; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; KI 67 ANTIGEN; MESSENGER RNA; SHORT HAIRPIN RNA; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CHEMOKINE CXCL5; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 77949567045     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.006     Document Type: Article

References (38)

1. McMahon S., and Chen A.Y. Head and neck cancer. Cancer Metast Rev 22 (2003) 21-24
2. Perez-Ordonez B., Beauchemin M., and Jordan R.C. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59 (2006) 445-453
3. Walsh J.E., Lathers D.M., Chi A.C., Gillespie M.B., Day T.A., and Young M.R. Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol 8 (2007) 227-238
4. Miyahara M., Tanuma J., Sugihara K., and Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110 (2007) 1287-1294
5. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
6. Dorsam R.T., and Gutkind J.S. G-protein-coupled receptors and cancer. Nat Rev Cancer 7 (2007) 79-94
7. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (1992) 845-848
8. Ferrara N. Vascular endothelial growth factor. Basic science and clinical progress. Endocr Rev 25 (2004) 581-611
9. Kowanetz M., and Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12 (2006) 5018-5022
10. Bacon K., Baggiolini M., Broxmeyer H., Horuk R., Lindley I., Mantovani A., et al. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22 (2002) 1067-1068
11. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
12. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
13. Strieter R.M., Belperio J.A., Phillips R.J., and Keane M.P. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14 (2004) 195-200
14. Christofakis E.P., Miyazaki H., Rubink D.S., and Yeudall W.A. Roles of CXCL8 in squamous cell carcinoma proliferation and migration. Oral Oncol 44 (2008) 920-926
15. Miyazaki H., Patel V., Wang H., Edmunds R.K., Gutkind J.S., and Yeudall W.A. Downregulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res 66 (2006) 4279-4284
16. Mayumi M., Jun-ichi T., Kazumasa S., and Ichiro S. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110 (2007) 1287-1294
17. Warburton G., Nikitakis N.G., Roberson P., Marinos N.J., Wu T., Sauk J.J., et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 65 (2007) 475-484
18. Yeudall W.A., Crawford R.Y., Ensley J.F., and Robbins K.C. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15 (1994) 2683-2686
19. Cardinali M., Pietraszkiewicz H., Ensley J.F., and Robbins K.C. Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 61 (1995) 98-103
20. Miyazaki H., Patel V., Wang H., Ensley J.F., Gutkind J.S., and Yeudall W.A. Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. Oral Oncol 42 (2006) 240-256
21. Cross M.J., Dixelius J., Matsumoto T., and Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 28 (2003) 488-494
22. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001 (2001) RE21
23. Martin D., Galisteo R., and Gutkind J.S. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 284 (2009) 6038-6042
24. Kowalski L.P., and Medina J.E. Nodal metastases: predictive factors. Otolaryngol Clin North Am 31 (1998) 621-637
25. O-Charoenrat P., Rhys-Evans P., and Eccles S.A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92 (2001) 556-568
26. Siriwardena B.S.M.S., Kudo Y., Ogawa I., Udagama M.N.G.P.K., Tilakaratne W.M., and Takata T. VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clin Pathol 61 (2008) 103-108
27. Chandrasekar B., Melby P.C., Sarau H.M., Raveendran M., Perla R.P., Marelli-Berg F.M., et al. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem 278 (2003) 4675-4686
28. Wang D., Sai J., Carter G., Sachpatzidis A., Lolis E., and Richmond A. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 41 (2002) 7100-7107
29. Wang D., and Richmond A. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway. J Biol Chem 276 (2001) 3650-3659
30. Chandrasekar B., Bysani S., and Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 279 (2004) 3188-3196
31. Venkatakrishnan G., Salgia R., and Groopman J.E. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275 (2000) 6868-6875
32. Sanchez-Sanchez N., Riol-Blanco L., De La Rosa G., Puig-Kroger A., Garcia-Bordas J., Martin D., et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104 (2004) 619-625
33. Wang J., Sun Y., Song W., Nor J.E., Wang C.Y., and Taichman R.S. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17 (2005) 1578-1592
34. Tan W., Martin D., and Gutkind J.S. The G{alpha}13-rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem 281 (2006) 39542-39549
35. Wang J., Zhang X., Thomas S.M., Grandis J.R., Wells A., Chen Z.G., et al. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and pro survival pathways in head and neck cancer cells independent of EGFR. Oncogene 24 (2005) 5897-5904
36. Luppi F., Longo A.M., de Boer W.I., Rabe K.F., and Hiemstra P.S. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56 (2007) 25-33
37. Raskopf E., Vogt A., Sauerbruch T., and Schmitz V. SiRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J Hepatol 49 (2008) 977-984
38. Saidi A., Hagedorn M., Allain N., Verpelli C., Sala C., Bello L., et al. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 125 (2009) 1054-1064